search forAventis Pharmaceuticals, Inc.
Instead search for Aventis Pharmaceuticals (113 Results)
44
07/29/2003
05/10/2005
-
CANCELLED - SECTION 8
1644
11/13/2002
03/08/2005
-
CANCELLED - SECTION 8
5
08/30/2002
01/20/2004
-
CANCELLED - SECTION 8
5
08/30/2002
12/09/2003
-
CANCELLED - SECTION 8
542
11/09/2001
09/03/2002
-
CANCELLED - SECTION 8
1642
06/01/2001
01/28/2003
-
CANCELLED - SECTION 8
41
12/21/2000
06/17/2003
-
CANCELLED - SECTION 8
That’s Why a Free TMDB Account Is Worthwhile
Monitor and protect brands
If you have set up trademark monitoring, you will automatically receive an email about copycats and free riders. This is how uncomplicated real-time brand protection works.
Follow brands easily
If you follow a trade mark, you will receive an e-mail when new applications, oppositions, deadlines, renewals and much more are filed. - This way, you can stay up to date on the development of a trade mark.
Sign up for free
5
08/23/2004
-
-
ABANDONED - NO STATEMENT OF USE FILED
1644
06/04/2004
-
-
ABANDONED - NO STATEMENT OF USE FILED
44
07/29/2003
05/10/2005
-
CANCELLED - SECTION 8
1642
07/11/2003
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
1642
07/10/2003
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
1644
05/13/2003
-
-
ABANDONED - NO STATEMENT OF USE FILED
16
04/30/2003
-
-
ABANDONED - NO STATEMENT OF USE FILED
1644
02/05/2003
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
1644
11/13/2002
03/08/2005
-
CANCELLED - SECTION 8
44
11/12/2002
-
-
ABANDONED - NO STATEMENT OF USE FILED
5
08/30/2002
01/20/2004
-
CANCELLED - SECTION 8
5
08/30/2002
12/09/2003
-
CANCELLED - SECTION 8
5
08/30/2002
-
-
ABANDONED - NO STATEMENT OF USE FILED
91641
08/21/2002
-
-
ABANDONED - NO STATEMENT OF USE FILED
1644
07/26/2002
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
1644
07/25/2002
-
-
ABANDONED - NO STATEMENT OF USE FILED
5
06/18/2002
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Search results 41 - 81 of 94
We love brands.
And are happy to look after you.
You can reach us from Monday to Friday between 08:00-16:00.
